Allogene Therapeutics Appoints Timothy Moore as Chief
Former Kite Pharma Executive Responsible for the Development and Commercial Launch of Two of the Most Successful Autologous CAR T Manufacturing Processes...
Source: globenewswire.com
Page 5 - Commercial Launch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Commercial Launch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Commercial Launch Today - Breaking & Trending Today
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Advanced preparations for potential commercial launch of BT-001 in U.S. in mid-2023 Reported positive topline results from exploratory trial for fatty liver disease Announced restructuring and... | March 30, 2023
Source: marketscreener.com
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
VOXZOGO $169 Million Contribution Drives Record Full Year 2022 Total Revenues of $2.1 Billion In 2023, More than 15% Growth in Total Revenues and Approximately...
Source: prnewswire.com
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2022 and Provides Financial Expectations for 2023
- Revenues of $1.11 Billion in 2022, GAAP Loss per Share of $0.97 and Diluted Non-GAAP Earnings per Share of $0.34 - - Achieved LYBALVI® Net Sales of $96.0 Million in First Full Year
Source: finanznachrichten.de